CSL Behring UK Limited

Hayworth House, Market Place, Haywards Heath, West Sussex, RH16 1DB, UK
Telephone: +44 (0)1444 447 400
Fax: +44 (0)1444 447 403
Medical Information Direct Line: +44 (0)1444 447 405
Medical Information e-mail: medinfo@cslbehring.com
Customer Care direct line: +44 (0)1444 447 402
Out of Hours e-mail: +44 (0)1444 447 405
Summary of Product Characteristics last updated on the eMC: 28/09/2007
SPC Rhophylac 300 (1500 IU)

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 28/09/2007 and displayed until Current
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
Date of revision of text on the SPC:   09/2007
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Section  7: Company name change from ZLB Behring to CSL Behring
Updated on 19/07/2006 and displayed until 28/09/2007
Reasons for adding or updating:
  • Change to section 2 - qualitative and quantitative composition
  • Change to section 4.4 - Special Warnings and Precautions for Use
  • Change to section 8 - MA number
  • Change to section 9 - Date of Renewal of Authorisation
  • Change to section 10 (date of (partial) revision of the text
Date of revision of text on the SPC:   06/2006
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Section 2 - included concentration of 750IU (150 mcg)
Section 4.4 - revised Information on safety with respect to transmissible agents
Section 8 - Included new PL  nubmer PL15036/0019
Section 9 - Renewal of  product licence, hence renewal date changed
Section 10 - Text revision date updated
Updated on 19/12/2003 and displayed until 19/07/2006
Reasons for adding or updating:
  • Change to section 2 - qualitative and quantitative composition
  • Change to section 4.2 - Posology and Method of Administration
  • Change to section 4.4 - Special Warnings and Precautions for Use
  • Change to section 4.5 - Interactions with other Medicaments and other forms of Interaction
Updated on 03/10/2003 and displayed until 19/12/2003
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 23/04/2003 and displayed until 03/10/2003
Reasons for adding or updating:
  • New SPC for new product

Active Ingredients/Generics

 
   anti-d(rho)


© 2010 Datapharm Communications Ltd

Go to www.medicines.org.uk